Carboxyl terminus of heat shock protein 70-interacting protein inhibits angiotensin II-induced cardiac remodeling

Am J Hypertens. 2012 Sep;25(9):994-1001. doi: 10.1038/ajh.2012.74. Epub 2012 Jun 21.

Abstract

Background: The carboxyl terminus of heat shock protein 70-interacting protein (CHIP), an E3 ligase/chaperone, was found to protect cardiomyocytes against apoptosis induced by ischemic injury; however, the functional role of CHIP in remodeling induced by angiotensin II (Ang II) remains unclear.

Methods: We generated CHIP-overexpressed transgenic (TG) mice infused with Ang II (1,500 ng/kg/min) or saline for days or small interfering RNA (siRNA) knockdown of neonatal rat cardiomyocytes. Heart sections were stained with hematoxylin and eosin, Masson trichrome, TdT-mediated dUTP nick-end labeling (TUNEL) staining, and immunohistochemistry, and the levels of nuclear factor-κB (NF-κB) and mitogen-activated protein kinases (MAPK) were measured by western blot analysis.

Results: Seven days after Ang II infusion, cardiac-specific overexpression of CHIP significantly enhanced cardiac contractile performance in mice and attenuated cardiac apoptosis, fibrosis, and inflammation: the number of TUNEL-positive cells, fibrotic areas, macrophage infiltration, and the expression of interleukin-1β (IL-1β), IL-6, monocyte chemoattractant protein-1 (MCP-1) and intercellular adhesion molecule-1 (ICAM-1) in heart tissues were decreased as compared with wild-type (WT) mice (all P < 0.05). In contrast, CHIP siRNA knockdown markedly increased Ang II-induced apoptosis and the expression of proinflammatory cytokines, as compared with siRNA control. The mechanisms underlying these beneficial actions were associated with CHIP-mediated inhibition of NF-κB and MAPK (p38 and JNK) pathways.

Conclusions: CHIP plays an important role in regulating Ang II-triggered hypertensive cardiac apoptosis, inflammation, and fibrosis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Angiotensin II / drug effects*
  • Angiotensins / antagonists & inhibitors*
  • Animals
  • Apoptosis / drug effects
  • Fibrosis
  • Heart / drug effects*
  • Mice
  • Mice, Transgenic
  • Mitogen-Activated Protein Kinases / metabolism
  • Myocardium / pathology
  • Myocytes, Cardiac
  • NF-kappa B / antagonists & inhibitors
  • Rats
  • Ubiquitin-Protein Ligases / biosynthesis
  • Ubiquitin-Protein Ligases / physiology*
  • Ventricular Remodeling / physiology

Substances

  • Angiotensins
  • NF-kappa B
  • Angiotensin II
  • Stub1 protein, mouse
  • Ubiquitin-Protein Ligases
  • Mitogen-Activated Protein Kinases